1-10 of 10
Aleksandr Lazaryan
Close
Sort by
Journal Articles

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma

Jennifer M. Logue, Lauren C. Peres, Hamza Hashmi, Christelle M. Colin-Leitzinger, Alexandria M. Shrewsbury, Hitomi Hosoya, Rebecca M. Gonzalez, Christina Copponex, Krista H. Kottra, Vanna Hovanky, Bita Sahaf, Sunita Patil, Aleksandr Lazaryan, Michael D. Jain, Aliyah Baluch, Olga V. Klinkova, Nelli Bejanyan, Rawan G. Faramand, Hany Elmariah, Farhad Khimani, Marco L. Davila, Asmita Mishra, Brandon J. Blue, Ariel F. Grajales-Cruz, Omar A. Castaneda Puglianini, Hien D. Liu, Taiga Nishihori, Ciara L. Freeman, Jason B. Brayer, Kenneth H. Shain, Rachid C. Baz, Frederick L. Locke, Melissa Alsina, Surbhi Sidana, Doris K. Hansen
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6109–6119.
https://doi.org/10.1182/bloodadvances.2022008320
Published: 2022
Includes: Supplemental data
Journal Articles

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL

Ariel Perez, Grace Johnson, Kedar Patel, Brian Arciola, Anthony Wood, Christina A. Bachmeier, Julio C. Chavez, Bijal D. Shah, Farhad Khimani, Taiga Nishihori, Aleksandr Lazaryan, Marco L. Davila, Rahul Mhaskar, Frederick L. Locke, Sameh Gaballa, Michael D. Jain
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3970–3973.
https://doi.org/10.1182/bloodadvances.2022007006
Published: 2022
Includes: Supplemental data
Journal Articles

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis

Mehdi Hamadani, Ajay K. Gopal, Marcelo Pasquini, Soyoung Kim, Xianmiao Qiu, Sairah Ahmed, Aleksandr Lazaryan, Vijaya Raj Bhatt, Andrew Daly, Premal Lulla, Stefan Ciurea, Jordan Gauthier, Vaibhav Agrawal, Natalie S. Grover, Lazaros Lekakis, Dipenkumar Modi, Parastoo B. Dahi, Megan M. Herr, P. Connor Johnson, Hamza Hashmi, Peiman Hematti, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2022) 6 (2): 486–494.
https://doi.org/10.1182/bloodadvances.2021005788
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease

Clinical Trials & Observations
Aleksandr Lazaryan, Stephanie Lee, Mukta Arora, Jongphil Kim, Brian Christopher Betts, Farhad Khimani, Taiga Nishihori, Nelli Bejanyan, Hien Liu, Mohamed A. Kharfan-Dabaja, Frederick L. Locke, Rebecca Gonzalez, Michael D. Jain, Marco L. Davila, Lia Elena Perez, Asmita Mishra, Ariel Perez Perez, Karlie Balke, Ernesto Ayala, Leonel Ochoa, Omar Castaneda Puglianini, Rawan Faramand, Melissa Alsina, Hany Elmariah, Michael L. Nieder, Hugo Fernandez, Claudio Anasetti, Joseph A. Pidala
Journal: Blood Advances
Blood Adv (2022) 6 (1): 259–269.
https://doi.org/10.1182/bloodadvances.2021005552
Published: 2022
Includes: Supplemental data
Journal Articles

A phase 2 trial of GVHD prophylaxis with PTCy, sirolimus, and MMF after peripheral blood haploidentical transplantation

Clinical Trials & Observations
Nelli Bejanyan, Joseph A. Pidala, Xuefeng Wang, Ram Thapa, Taiga Nishihori, Hany Elmariah, Aleksandr Lazaryan, Farhad Khimani, Marco L. Davila, Asmita Mishra, Rawan Faramand, Michael D. Jain, Leonel Ochoa, Lia Elena Perez, Hien Liu, Melissa Alsina, Mohamed A. Kharfan-Dabaja, Hugo Fernandez, Michael L. Nieder, Frederick L. Locke, Claudio Anasetti, Ernesto Ayala
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1154–1163.
https://doi.org/10.1182/bloodadvances.2020003779
Published: 2021
Journal Articles

Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphoma

Clinical Trials & Observations
Hamza Hashmi, Abu-Sayeef Mirza, Alicia Darwin, Constantine Logothetis, Franco Garcia, Anuhya Kommalapati, Rahul S. Mhaskar, Christina Bachmeier, Julio C. Chavez, Bijal Shah, Javier Pinilla-Ibarz, Farhad Khimani, Aleksandr Lazaryan, Hien Liu, Marco L. Davila, Frederick L. Locke, Taiga Nishihori, Michael D. Jain
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4086–4090.
https://doi.org/10.1182/bloodadvances.2020002060
Published: 2020
Includes: Supplemental data
Journal Articles

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Erin A. Dean, Rahul S. Mhaskar, Hong Lu, Mina S. Mousa, Gabriel S. Krivenko, Aleksandr Lazaryan, Christina A. Bachmeier, Julio C. Chavez, Taiga Nishihori, Marco L. Davila, Farhad Khimani, Hien D. Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Michael D. Jain, Yoganand Balagurunathan, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3268–3276.
https://doi.org/10.1182/bloodadvances.2020001900
Published: 2020
Includes: Supplemental data
Journal Articles

Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Celalettin Ustun, Erica D. Warlick, Mukta Arora, John E. Wagner, Daniel J. Weisdorf
Journal: Blood Advances
Blood Adv (2019) 3 (3): 230–236.
https://doi.org/10.1182/bloodadvances.2018018549
Published: 2019
Journal Articles

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802

Clinical Trials & Observations
Shernan G. Holtan, Todd E. DeFor, Angela Panoskaltsis-Mortari, Nandita Khera, John E. Levine, Mary E. D. Flowers, Stephanie J. Lee, Yoshihiro Inamoto, George L. Chen, Sebastian Mayer, Mukta Arora, Jeanne Palmer, Corey S. Cutler, Sally Arai, Aleksandr Lazaryan, Laura F. Newell, Madan H. Jagasia, Iskra Pusic, William A. Wood, Anne S. Renteria, Gregory Yanik, William J. Hogan, Elizabeth Hexner, Francis Ayuk, Ernst Holler, Udomsak Bunworasate, Yvonne A. Efebera, James L. M. Ferrara, Joseph Pidala, Alan Howard, Juan Wu, Javier Bolaños-Meade, Vincent Ho, Amin Alousi, Bruce R. Blazar, Daniel J. Weisdorf, Margaret L. MacMillan
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1882–1888.
https://doi.org/10.1182/bloodadvances.2018017343
Published: 2018
Includes: Supplemental data
Journal Articles

Delayed immune reconstitution after allogeneic transplantation increases the risks of mortality and chronic GVHD

Nelli Bejanyan, Claudio G. Brunstein, Qing Cao, Aleksandr Lazaryan, Xianghua Luo, Julie Curtsinger, Rohtesh S. Mehta, Erica Warlick, Sarah A. Cooley, Bruce R. Blazar, Jeffrey S. Miller, Daniel Weisdorf, John E. Wagner, Michael R. Verneris
Journal: Blood Advances
Blood Adv (2018) 2 (8): 909–922.
https://doi.org/10.1182/bloodadvances.2017014464
Published: 2018
Includes: Supplemental data